You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

MFOLFOX6

Cancer Type: Gastrointestinal, Colorectal, Small bowel and appendix      Intent: Adjuvant
Regimen Category: Evidence-Informed
Funding:
New Drug Funding Program
    Oxaliplatin - Adjuvant Colorectal Small Bowel or Appendiceal Cancer
New Drug Funding Program
    Oxaliplatin - With Surgery for Curative Intent for CRC SBAC Pts with Resectable or Potentially Resectable Liver Mets
Evidence Building Program
    Oxaliplatin (EBP) - Colorectal Cancer Patients with Resectable or Potentially Resectable Extrahepatic Metastases
Evidence Building Program
    Oxaliplatin (EBP) - Supplemental 1
Evidence Building Program
    Oxaliplatin (EBP) - Supplemental 2

You might also be interested in